Salix Class Attys Seek $44.6M In Fees For $210M Settlement
Attorneys who secured a tentative $210 million settlement to end a proposed class action by Salix Pharmaceuticals Ltd. shareholders claiming the company misrepresented inventory levels to falsely inflate its stock price...To view the full article, register now.
Already a subscriber? Click here to view full article